GO:0071722 detoxification of arsenic-containing substance: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0071722 describes the biological process that reduces or removes the toxicity of arsenic-containing compounds, including arsenates, arsenites, and arsenides.
• Detoxification involves transport of arsenic away from sensitive cellular areas and sequestration into compartments or complexes that safely store the toxic species.
• Arsenic toxicity is linked to disruption of endoplasmic reticulum-lysosomal calcium ion transport and lysosomal autophagy activity via the IP3R/TRPML1 pathway.
• Key proteins in arsenic detoxification include arsenite methyltransferases, multidrug resistance-associated proteins, and glutathione S-transferases, which facilitate methylation, efflux, and conjugation.
• Dysregulation of arsenic detoxification is associated with liver injury, cancers, and neurodegenerative conditions.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable precise dissection of genes involved in arsenic detoxification.
Description
Arsenic is a widespread environmental toxicant that poses significant health risks to humans and animals. The biological process termed detoxification of arsenic-containing substance (GO:0071722) encompasses all mechanisms that reduce or remove the toxicity of arsenic compounds, including arsenates, arsenites, and arsenides. This process is essential for cellular protection against arsenic-induced damage, which can manifest as liver injury, cancer, and neurological disorders. Understanding the molecular players and regulatory pathways of arsenic detoxification is critical for developing therapeutic interventions and for assessing environmental health risks. Recent studies have highlighted the role of endoplasmic reticulum-lysosomal calcium ion transport and lysosomal autophagy in arsenic-induced toxicity, providing new insights into how cells attempt to detoxify arsenic. Researchers studying this process can leverage CRISPR-based models to dissect the contribution of individual genes and pathways.
detoxification of arsenic-containing substance At A Glance
| GO ID | GO:0071722 |
|---|---|
| GO term | detoxification of arsenic-containing substance |
| Ontology | biological_process |
| Synonym | detoxification of arsenic |
| Major function | Reduction or removal of toxicity of arsenic-containing compounds via transport and sequestration |
| Related pathways | Endoplasmic reticulum-lysosomal calcium ion transport, lysosomal autophagy, IP3R/TRPML1 signaling |
| Associated diseases | Liver injury, cancer, neurodegenerative disorders |
| Key cellular compartments | Endoplasmic reticulum, lysosomes, cytoplasm |
What Is GO:0071722?
GO:0071722, detoxification of arsenic-containing substance, is defined as any process that reduces or removes the toxicity of compounds containing arsenic, including arsenates, arsenites, and arsenides. These processes include the transport of such compounds away from sensitive areas and to compartments or complexes whose purpose is sequestration of arsenic or arsenic-containing compounds.
Why Is detoxification of arsenic-containing substance Important in Cell Biology?
Arsenic contamination affects millions worldwide, and the ability of cells to detoxify arsenic is a critical determinant of susceptibility to arsenic-related diseases. The process GO:0071722 is vital for maintaining cellular homeostasis and preventing arsenic-induced damage to organelles such as the endoplasmic reticulum and lysosomes. Disruption of this process can lead to liver injury, as demonstrated by arsenic-induced inhibition of ER-lysosomal calcium ion transport and lysosomal autophagy via the IP3R/TRPML1 pathway. Therefore, understanding the genetic and molecular basis of arsenic detoxification is essential for developing preventive and therapeutic strategies.
• Protects cells from arsenic-induced oxidative stress and organelle damage.
• Prevents arsenic accumulation in sensitive tissues such as the liver.
• Modulates risk of arsenic-related cancers and chronic diseases.
• Involves calcium signaling and autophagy pathways that are broadly relevant to cell stress responses.
• Provides targets for therapeutic intervention in arsenic poisoning.
• Informs environmental health risk assessments and regulatory standards.
• Helps explain inter-individual differences in arsenic susceptibility.
• Links to neurodegenerative processes through shared mechanisms of metal detoxification.
What Happens During detoxification of arsenic-containing substance?
Uptake and recognition of arsenic compounds
In simple terms: Cells first take in arsenic and recognize it as a harmful substance.
Arsenic enters cells through transporters such as aquaporins and phosphate transporters. Once inside, arsenate can be reduced to arsenite, which is more toxic. The cell recognizes these species as threats, triggering detoxification responses.
Transport away from sensitive areas
In simple terms: The cell moves arsenic away from important parts to keep them safe.
Arsenic and its metabolites are actively transported out of sensitive compartments like the nucleus and mitochondria. This transport often involves ATP-binding cassette (ABC) transporters and multidrug resistance-associated proteins (MRPs) that pump arsenic conjugates out of the cell or into storage organelles.
Sequestration into compartments
In simple terms: Arsenic is locked away in safe containers inside the cell.
Arsenic can be sequestered into lysosomes and other vesicles. Recent evidence indicates that arsenic disrupts ER-lysosomal calcium ion transport and lysosomal autophagy via the IP3R/TRPML1 pathway, suggesting that lysosomal sequestration is a key detoxification mechanism.
Biochemical modification and conjugation
In simple terms: The cell chemically changes arsenic to make it less harmful.
Arsenite methyltransferases (AS3MT) methylate arsenite to less toxic methylated species. Glutathione S-transferases (GSTs) conjugate arsenic with glutathione, facilitating efflux. These modifications enhance detoxification and excretion.
Autophagy and lysosomal degradation
In simple terms: The cell recycles damaged parts and clears arsenic through autophagy.
Arsenic-induced autophagy can be protective or detrimental depending on context. Inhibition of lysosomal autophagy activity by arsenic via the IP3R/TRPML1 pathway exacerbates toxicity, indicating that proper autophagic flux is required for detoxification.
Key Genes Involved in GO:0071722 detoxification of arsenic-containing substance
The following genes and proteins are involved in the detoxification of arsenic-containing substances, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| AS3MT | Arsenite methyltransferase; methylates arsenite to less toxic species | Key enzyme in arsenic metabolism; polymorphisms affect susceptibility |
| GSTO1 | Glutathione S-transferase omega; reduces arsenate and conjugates arsenic | Modulates arsenic toxicity and cancer risk |
| GSTP1 | Glutathione S-transferase pi; detoxifies arsenic via conjugation | Potential biomarker for arsenic-related diseases |
| ABCC1 (MRP1) | Multidrug resistance-associated protein; effluxes arsenic-glutathione conjugates | Mediates cellular export of arsenic |
| ABCC2 (MRP2) | Multidrug resistance-associated protein; transports arsenic conjugates | Involved in biliary excretion of arsenic |
| AQP9 | Aquaglyceroporin; facilitates arsenite uptake | Determines cellular arsenic sensitivity |
| SLC34A2 | Phosphate transporter; mediates arsenate uptake | Affects arsenic accumulation |
| IP3R | Inositol 1,4,5-trisphosphate receptor; regulates ER calcium release | Arsenic inhibits ER-lysosomal calcium transport via IP3R |
| TRPML1 | Mucolipin 1; lysosomal calcium channel | Arsenic impairs lysosomal autophagy via TRPML1 |
| ATG5 | Autophagy-related 5; essential for autophagosome formation | Modulates arsenic-induced autophagy |
| ATG7 | Autophagy-related 7; required for autophagy | Affects arsenic detoxification through autophagy |
| SQSTM1 (p62) | Sequestosome 1; cargo receptor for selective autophagy | Links arsenic-induced stress to autophagy |
| NFE2L2 (NRF2) | Transcription factor; regulates antioxidant response | Activates detoxification genes upon arsenic exposure |
| MT1A | Metallothionein 1A; binds heavy metals including arsenic | Protects against arsenic toxicity |
| MT2A | Metallothionein 2A; sequesters arsenic | Contributes to arsenic detoxification |
| HMOX1 | Heme oxygenase 1; antioxidant enzyme | Induced by arsenic as a protective response |
| GCLC | Glutamate-cysteine ligase catalytic subunit; glutathione synthesis | Supports glutathione-mediated arsenic conjugation |
| GCLM | Glutamate-cysteine ligase modifier subunit; glutathione synthesis | Modulates cellular glutathione and arsenic detoxification |
How Is detoxification of arsenic-containing substance Regulated?
The detoxification of arsenic-containing substances is regulated at multiple levels. The transcription factor NRF2 (NFE2L2) activates antioxidant response elements (ARE) to induce genes such as HMOX1, GCLC, and GSTs upon arsenic exposure. Arsenic also modulates calcium signaling through IP3R and TRPML1, affecting lysosomal autophagy and ER-lysosomal calcium transport. Autophagy-related proteins such as ATG5 and ATG7 are regulated by nutrient-sensing pathways including mTOR, which can influence arsenic detoxification capacity. Additionally, epigenetic modifications and microRNAs have been implicated in regulating arsenic detoxification genes, though further studies are needed.
detoxification of arsenic-containing substance and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| AS3MT | Arsenic metabolism and cancer susceptibility | Knockout in HepG2 cells; point mutation for polymorphisms |
| GSTO1 | Arsenic toxicity and cancer risk | Overexpression in HEK293; knockout in keratinocytes |
| IP3R | Arsenic-induced liver injury via ER calcium | Knockout in mouse hepatocytes; point mutation |
| TRPML1 | Lysosomal autophagy dysfunction | Knock-in of disease mutations; knockout in HeLa |
| NFE2L2 | Antioxidant response and arsenic detoxification | Knockout in A549; overexpression in primary cells |
Arsenic-induced liver injury
Arsenic exposure causes liver injury by inhibiting endoplasmic reticulum-lysosomal calcium ion transport and lysosomal autophagy activity via the IP3R/TRPML1 pathway. This disruption leads to accumulation of damaged organelles and cell death, highlighting the importance of detoxification mechanisms in hepatoprotection.
Arsenic and cancer
Chronic arsenic exposure is associated with skin, lung, bladder, and liver cancers. Polymorphisms in AS3MT, GSTO1, and GSTP1 influence arsenic metabolism and cancer susceptibility. Detoxification efficiency determines the internal dose of carcinogenic arsenic metabolites.
Neurodegenerative disorders
Arsenic neurotoxicity has been linked to cognitive impairment and neurodegenerative diseases. Impaired arsenic detoxification may exacerbate oxidative stress and protein aggregation in neurons. The IP3R/TRPML1 pathway is also implicated in neuronal calcium dyshomeostasis.
From detoxification of arsenic-containing substance-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does AS3MT knockout increase arsenic sensitivity? | CRISPR knockout in HepG2 or HEK293 cells |
| How do AS3MT polymorphisms affect enzyme activity? | Point mutation knock-in of SNP variants |
| Can overexpression of GSTO1 protect against arsenic? | Overexpression cell lines |
| What is the role of TRPML1 in lysosomal arsenic sequestration? | Knock-in of tagged TRPML1 for imaging |
| Does NRF2 activation enhance arsenic detoxification? | Knockout and overexpression of NFE2L2 |
| Which genes are essential for arsenic-induced autophagy? | CRISPR library screening for autophagy regulators |
How to Study the detoxification of arsenic-containing substance Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screen | Gene essentiality under arsenic stress | Identify novel detoxification genes |
| RNA-seq | Transcriptional response to arsenic | Discover NRF2 target genes |
| Proteomics | Protein abundance and modifications | Map arsenic-induced signaling |
| Live-cell calcium imaging | ER and lysosomal calcium dynamics | Assess IP3R/TRPML1 function |
| Autophagy flux assay | LC3 turnover and lysosomal activity | Evaluate arsenic effects on autophagy |
| ICP-MS | Intracellular arsenic concentration | Measure detoxification efficiency |
| Western blot | Protein expression and cleavage | Validate knockout/overexpression |
| qPCR | mRNA levels of detoxification genes | Confirm transcriptional changes |
CRISPR knockout screening
Genome-wide CRISPR knockout screens can identify genes whose loss alters cell survival under arsenic exposure. This approach has revealed novel regulators of arsenic detoxification and autophagy.
RNA sequencing (RNA-seq)
RNA-seq measures transcriptional changes upon arsenic treatment, revealing induction of detoxification genes such as NFE2L2 targets, metallothioneins, and GSTs.
Proteomics and phosphoproteomics
Mass spectrometry-based proteomics can quantify arsenic-induced changes in protein abundance and post-translational modifications, identifying key effectors in detoxification pathways.
Live-cell imaging of calcium and lysosomes
Fluorescent indicators for calcium (e.g., GCaMP) and lysosomal markers (e.g., LysoTracker) enable real-time monitoring of arsenic effects on ER-lysosomal calcium transport and autophagy.
How CRISPR Can Be Used to Study GO:0071722 detoxification of arsenic-containing substance
Knockout
CRISPR knockout of genes such as AS3MT, GSTO1, or TRPML1 allows researchers to assess their contribution to arsenic detoxification. For example, AS3MT knockout cells show altered arsenic methylation and increased sensitivity.
Point Mutation
Introducing disease-associated or functional SNPs (e.g., in AS3MT or GSTO1) via CRISPR point mutation enables precise evaluation of their impact on enzyme activity and arsenic metabolism.
Knock-in
Knock-in of tagged versions of proteins like TRPML1 or IP3R facilitates live-cell imaging and interaction studies under arsenic exposure.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression can boost levels of protective genes such as NFE2L2 or GSTs to test whether enhanced detoxification mitigates arsenic toxicity.
How EDITGENE Supports detoxification of arsenic-containing substance Research
Researchers studying detoxification of arsenic-containing substance-related genes often need to determine whether a candidate gene is causally involved in arsenic resistance, metabolism, or toxicity. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from gene knockout to precise point mutations and library screening.
Contact EDITGENE today to design your custom CRISPR model for detoxification of arsenic-containing substance research.
Frequently Asked Questions About detoxification of arsenic-containing substance
What is GO:0071722 detoxification of arsenic-containing substance?
GO:0071722 is a biological process that reduces or removes the toxicity of arsenic-containing compounds, including arsenates, arsenites, and arsenides, through transport and sequestration mechanisms.
What genes are involved in detoxification of arsenic-containing substance?
Key genes include AS3MT, GSTO1, GSTP1, ABCC1, ABCC2, AQP9, SLC34A2, IP3R, TRPML1, ATG5, ATG7, SQSTM1, NFE2L2, MT1A, MT2A, HMOX1, GCLC, and GCLM.
How does arsenic cause liver injury?
Arsenic induces liver injury by inhibiting endoplasmic reticulum-lysosomal calcium ion transport and lysosomal autophagy activity via the IP3R/TRPML1 pathway.
What is the role of autophagy in arsenic detoxification?
Autophagy helps sequester and degrade arsenic-damaged organelles; inhibition of lysosomal autophagy by arsenic exacerbates toxicity.
Which CRISPR models are used to study arsenic detoxification?
Knockout, point mutation, knock-in, and overexpression models of genes like AS3MT, GSTO1, and TRPML1 are commonly used.
What diseases are linked to arsenic detoxification defects?
Arsenic detoxification defects are linked to liver injury, cancers (skin, lung, bladder, liver), and neurodegenerative disorders.
How can I measure arsenic detoxification in cells?
Methods include ICP-MS for arsenic quantification, RNA-seq for gene expression, and live-cell imaging for calcium and autophagy.
What is the IP3R/TRPML1 pathway?
It is a calcium signaling pathway involving inositol trisphosphate receptor (IP3R) and lysosomal calcium channel TRPML1, which regulates ER-lysosomal calcium transport and autophagy; arsenic inhibits this pathway.
Can NRF2 activation protect against arsenic toxicity?
Yes, NRF2 (NFE2L2) induces antioxidant and detoxification genes such as HMOX1 and GSTs, enhancing arsenic detoxification.
What services does EDITGENE offer for arsenic detoxification research?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression cell models, library screening, and bioinformatics services.
Conclusion
GO:0071722 detoxification of arsenic-containing substance is a critical biological process that protects cells from arsenic toxicity through transport, sequestration, and biochemical modification. Dysregulation of this process is linked to liver injury, cancer, and neurodegenerative diseases. Advances in CRISPR-based models and multi-omics approaches are uncovering the molecular players and regulatory networks involved, offering new avenues for therapeutic intervention and risk assessment.
References
- 1. Qiao B et al.. 2026. Arsenic induces chicken liver injury by inhibiting endoplasmic reticulum-lysosomal calcium ion transport and lysosomal autophagy activity via the IP(3)R/TRPML1 pathway.. J Environ Sci (China) 166:81-95 PMID: 42336587
